Is surgery an option for metastatic Ovarian Cancer

Surgery for Metastatic Ovarian Cancer

This is an important question, and the answer is: yes, surgery can be an option for some patients with metastatic ovarian cancer, but it depends on several individual factors.

How Doctors Think About Surgery in Metastatic Ovarian Cancer

According to the medical literature and clinical guidelines, oncologists consider surgery for metastatic ovarian cancer using a framework called "oligometastatic disease" management. This means:

• Oligometastatic refers to cancer that has spread to a limited number of sites (typically 5 or fewer locations outside the primary tumor)
• The clinical reasoning is that if doctors can surgically remove ALL known disease sites (the primary tumor AND the metastatic spots), there may be a chance to delay progression or, in some cases, achieve long-term control

The concept is based on research showing that aggressive treatment of all visible disease—rather than treating it as widespread cancer—can improve outcomes in selected patients.

What the Evidence Shows

Research from clinical trials (like SABR-COMET and ORIOLE studies) demonstrates that patients who had all their disease completely removed had better outcomes than those with residual disease left behind. However, these studies also show that:

• Not all patients benefit equally from this approach
• Success depends on being able to remove ALL visible disease
• The location and accessibility of metastases matters significantly

General Treatment Approaches That Exist

For metastatic ovarian cancer, doctors typically consider:

1. Surgery followed by chemotherapy (standard approach)
2. Chemotherapy first, then surgery (neoadjuvant approach—treating before surgery)
3. Targeted therapies (especially PARP inhibitors for BRCA-positive patients)
4. Combination approaches (surgery + chemotherapy + targeted therapy)

According to the webinar on ovarian cancer tissue testing, ovarian cancer surgeons and oncologists are particularly open to coordinating care because they understand the importance of obtaining tissue for testing (like BRCA status and other biomarkers) while also performing surgery.

Critical Questions to Ask YOUR Oncology Team

Since your specific situation requires your doctor's evaluation, here are key questions to discuss:

1. "Based on my imaging and overall health, am I a candidate for surgery to remove all visible disease?"

   • This depends on tumor location, your performance status (ability to tolerate surgery), and whether complete removal is achievable

2. "If surgery is an option, would it be done before or after chemotherapy, and why?"

   • The timing significantly affects outcomes and side effects

3. "What is the goal of surgery in my case—curative intent, cytoreduction (reducing tumor burden), or tissue sampling?"

   • Different goals lead to different surgical approaches

4. "Have I been tested for BRCA mutations and other biomarkers that might affect my treatment plan?"

   • This information guides whether targeted therapies like PARP inhibitors should be part of your plan

5. "What are the specific risks of surgery given my metastatic sites and overall health?"

   • Understanding potential complications helps you make an informed decision

Important Considerations

• Tissue sampling: If surgery is planned, your team should coordinate to obtain tissue for molecular testing (BRCA, other mutations) to guide future treatment decisions
• Side effects: Surgery carries risks, especially if metastases are near vital organs or nerves
• Systemic disease: Even with successful surgery, metastatic ovarian cancer typically requires additional chemotherapy or targeted therapy afterward
• Individual factors: Your age, overall health, kidney/liver function, and other medical conditions all influence whether surgery is appropriate

Your Oncologist Makes the Final Decision

Your oncology team will determine the most appropriate approach based on:

• Your complete imaging studies
• Pathology findings
• Biomarker status (BRCA, HRD status, etc.)
• Your overall health and ability to tolerate treatment
• The specific locations of your metastases

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.